F8 and hemophilia: Furthermore, transfusion of desialylated FVIII-expressing transgenic platelets (2bF8Tg) in a murine model of hemophilia (FVIIInull) attenuated antibody responses following secondary recombinant human FVIII (rhFVIII) challenge.